RBC Capital analyst Ben Hendrix maintains $Encompass Health (EHC.US)$ with a buy rating, and adjusts the target price from $95 to $105.
According to TipRanks data, the analyst has a success rate of 62.2% and a total average return of 11.9% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Encompass Health (EHC.US)$'s main analysts recently are as follows:
Encompass Health has conveyed a positive stance regarding ongoing business tendencies and anticipates further growth in demand for its services. This follows a noteworthy streak where the company has consistently experienced a growth in same store discharges exceeding 4% for eight successive quarters, aligning with the upper threshold of their 2%-4% goal. Management, while not elaborating on the third-quarter performance, highlighted certain factors that might benefit the current yearly forecast. One such point is the assumption that new facilities will take longer to reach positive EBITDA compared to the previous year; however, if these facilities achieve a ramp-up rate similar to last year, it could signify potential upside.
The firm is revising its projections based on the company's Q2 earnings outperformance reported last month. It anticipates a persistent robust demand for post-acute services, supported by strong hospital admission growth projected by operators in the coverage through the end of the year, in addition to high hospital inpatient acuity and an enhancement in the length of stay.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
加皇資本市場分析師Ben Hendrix維持$Encompass Health (EHC.US)$買入評級，並將目標價從95美元上調至105美元。
根據TipRanks數據顯示，該分析師近一年總勝率為62.2%，總平均回報率為11.9%。
此外，綜合報道，$Encompass Health (EHC.US)$近期主要分析師觀點如下：
Encompass Health對持續的業務趨勢表示了積極的立場，並預計對其服務的需求將進一步增長。在此之前，該公司的同店出貨量連續八個季度持續增長超過4％，與其2％-4％的目標上限持平。管理層雖然沒有詳細說明第三季度的業績，但強調了可能有利於當前年度預測的某些因素。其中之一是假設新設施與去年相比需要更長的時間才能達到正的息稅折舊攤銷前利潤；但是，如果這些設施實現與去年相似的增長率，則可能意味着潛在的上升空間。
該公司正在根據該公司上個月公佈的第二季度收益跑贏大盤來修改其預測。它預計，對急症後服務的需求將持續強勁，這得益於運營商預計到年底的住院人數將實現強勁增長，此外住院患者敏銳度高，住院時間也將延長。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
